New study highlights Arcoxia's effectiveness for fasting headaches; Should Life Technologies go private?;

@FierceBiotech: Stem cells from ear can create new cartilage. News | Follow @FierceBiotech

@JohnCFierce: Wondering if the dread "Dendreon effect" will alter any biotech's future marketing plans for cancer drugs. Leave it to the experts? | Follow @JohnCFierce

@RyanMFierce: U.S.'s brand as 'land of opportunity' is in jeopardy, I think. China biotech entrepreneur's quote says it all. Article | Follow @RyanMFierce

@MaureenFierce: Genzyme VP: Rare-disease drug developers in it for 'long-haul.' Story | Follow @MaureenFierce

> A new study indicates that Arcoxia, a pain drug closely resembling Vioxx that proved too risky for U.S. regulators to approve, may be an effective treatment for the headaches induced by religious fasting. A large number of Muslims who fast during Ramadan complain of headaches. Piece

> Jon Groberg at Macquarie Equities Research is making the case that Life Technologies, which makes scientific equipment, should go private. More

> One of Boehringer Ingelheim's units is getting out of the contract manufacturing business. Story

Pharma News

@FiercePharma: Another cancer-drug rejection for NICE: Watchdog says AstraZeneca's Faslodex doesn't beat current therapy. News | Follow @FiercePharma

> As drug prices grow, payers dig into patients' wallets. News

> 'More bang for buck' from GSK's Cervarix. Details

> NICE nixes AZ's Faslodex in prelim guidance. Story

> Sanofi in talks to buy Indian OTC business. Report

Biotech Research News

> At last, a cause found for Lou Gehrig's disease. News

> Researchers build against body's natural defense against C. difficile. Article

> Stem cells from ears can create new cartilage. More

> A recipe for drug variation: Just add sugar. Story

> Stem cells to heart parts in 5 years, researchers say. Details

Manufacturing News

> WHO sends Panacea to remediation. More

> Meth makers to be foiled by jelly. Story

> Lilly, Genentech bolster QA functions. News

> Takeda parlays Baxter's vax methods into Japanese subsidies. Details

> Turbulence ahead for cancer drugs with Ben Venue exit. Report

> Sagent's vecuronium launch a hope against drug shortages. Article

And Finally... An international team of researchers say they have successfully created the first computerized genome-scale model of cancer cell metabolism, which can be used to predict which drugs are lethal to a cancer cell's metabolism. Release

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.